Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Farmers Insurance
US Department of Justice
Teva
Colorcon
Harvard Business School

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 6,444,671

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,444,671
Title: Cyclic AMP-specific phosphodiesterase inhibitors
Abstract:Novel compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed.
Inventor(s): Gaudino; John J. (Boulder, CO)
Assignee: ICOS Corporation (Bothell, WA)
Application Number:10/002,867
Patent Claims:see list of patent claims

Details for Patent 6,444,671

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Try a Free Trial ICOS Corporation (Bothell, WA) 2019-12-23 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Try a Free Trial ICOS Corporation (Bothell, WA) 2019-12-23 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Try a Free Trial ICOS Corporation (Bothell, WA) 2019-12-23 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
Johnson and Johnson
Chubb
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.